Enhancement of memory consolidation in chicks by β3-adrenoceptor agonists

Marie E. Gibbs, Roger J. Summers

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The effects of intracranial injection of three β3-adrenoceptor agonists, sodium-4-[-2[-2-hydroxy-2-(-3-chloro-phenyl)ethylamino] propyl]phenoxyacetate (BRL 37344), 2-hydroxy-5(2-((2-hydroxy-3-(4-((1-methyl-4-trifluoromethyl) 1H-imidazole-2-yl)-phenoxy)propyl)amino)ethoxy)-benzamide monomethane sulfonate) (±)-CGP12177A) and the pro-drug RS-N-(7-carbethoxymethoxyl 1,2,3,4-tetrahydronaphth-2-yl)-2 hydroxy 2-(3-chlorophenyl)ethanamine (SR58611A), were examined on reinforcement of memory in day-old chicks. BRL37344 and CGP12177 facilitated memory, whereas SR58611A had no effect. The dose-response relationships of the β3-adrenoceptor agonists were challenged with the selective β3-adrenoceptor antagonist 3-(2-ethylphenoxy)-1-[(1S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) or the β2-adrenoceptor antagonist (-)propranolol. BRL 37344 appeared to act predominantly at β3-adrenoceptors at low doses and at β2-adrenoceptors at higher doses. Facilitation of labile into long-term storage by β3-adrenoceptor agonists appears to be a class action of these drugs.

Original languageEnglish
Pages (from-to)235-240
Number of pages6
JournalEuropean Journal of Pharmacology
Volume413
Issue number2-3
DOIs
Publication statusPublished - 16 Feb 2001

Keywords

  • β-Adrenoceptor
  • (Chick)
  • Adrenoceptor
  • Consolidation
  • Memory
  • Memory, labile
  • Passive avoidance learning

Cite this

@article{97032b3950b543c99d4d3d3338ce8a71,
title = "Enhancement of memory consolidation in chicks by β3-adrenoceptor agonists",
abstract = "The effects of intracranial injection of three β3-adrenoceptor agonists, sodium-4-[-2[-2-hydroxy-2-(-3-chloro-phenyl)ethylamino] propyl]phenoxyacetate (BRL 37344), 2-hydroxy-5(2-((2-hydroxy-3-(4-((1-methyl-4-trifluoromethyl) 1H-imidazole-2-yl)-phenoxy)propyl)amino)ethoxy)-benzamide monomethane sulfonate) (±)-CGP12177A) and the pro-drug RS-N-(7-carbethoxymethoxyl 1,2,3,4-tetrahydronaphth-2-yl)-2 hydroxy 2-(3-chlorophenyl)ethanamine (SR58611A), were examined on reinforcement of memory in day-old chicks. BRL37344 and CGP12177 facilitated memory, whereas SR58611A had no effect. The dose-response relationships of the β3-adrenoceptor agonists were challenged with the selective β3-adrenoceptor antagonist 3-(2-ethylphenoxy)-1-[(1S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) or the β2-adrenoceptor antagonist (-)propranolol. BRL 37344 appeared to act predominantly at β3-adrenoceptors at low doses and at β2-adrenoceptors at higher doses. Facilitation of labile into long-term storage by β3-adrenoceptor agonists appears to be a class action of these drugs.",
keywords = "β-Adrenoceptor, (Chick), Adrenoceptor, Consolidation, Memory, Memory, labile, Passive avoidance learning",
author = "Gibbs, {Marie E.} and Summers, {Roger J.}",
year = "2001",
month = "2",
day = "16",
doi = "10.1016/S0014-2999(01)00757-9",
language = "English",
volume = "413",
pages = "235--240",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

Enhancement of memory consolidation in chicks by β3-adrenoceptor agonists. / Gibbs, Marie E.; Summers, Roger J.

In: European Journal of Pharmacology, Vol. 413, No. 2-3, 16.02.2001, p. 235-240.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Enhancement of memory consolidation in chicks by β3-adrenoceptor agonists

AU - Gibbs, Marie E.

AU - Summers, Roger J.

PY - 2001/2/16

Y1 - 2001/2/16

N2 - The effects of intracranial injection of three β3-adrenoceptor agonists, sodium-4-[-2[-2-hydroxy-2-(-3-chloro-phenyl)ethylamino] propyl]phenoxyacetate (BRL 37344), 2-hydroxy-5(2-((2-hydroxy-3-(4-((1-methyl-4-trifluoromethyl) 1H-imidazole-2-yl)-phenoxy)propyl)amino)ethoxy)-benzamide monomethane sulfonate) (±)-CGP12177A) and the pro-drug RS-N-(7-carbethoxymethoxyl 1,2,3,4-tetrahydronaphth-2-yl)-2 hydroxy 2-(3-chlorophenyl)ethanamine (SR58611A), were examined on reinforcement of memory in day-old chicks. BRL37344 and CGP12177 facilitated memory, whereas SR58611A had no effect. The dose-response relationships of the β3-adrenoceptor agonists were challenged with the selective β3-adrenoceptor antagonist 3-(2-ethylphenoxy)-1-[(1S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) or the β2-adrenoceptor antagonist (-)propranolol. BRL 37344 appeared to act predominantly at β3-adrenoceptors at low doses and at β2-adrenoceptors at higher doses. Facilitation of labile into long-term storage by β3-adrenoceptor agonists appears to be a class action of these drugs.

AB - The effects of intracranial injection of three β3-adrenoceptor agonists, sodium-4-[-2[-2-hydroxy-2-(-3-chloro-phenyl)ethylamino] propyl]phenoxyacetate (BRL 37344), 2-hydroxy-5(2-((2-hydroxy-3-(4-((1-methyl-4-trifluoromethyl) 1H-imidazole-2-yl)-phenoxy)propyl)amino)ethoxy)-benzamide monomethane sulfonate) (±)-CGP12177A) and the pro-drug RS-N-(7-carbethoxymethoxyl 1,2,3,4-tetrahydronaphth-2-yl)-2 hydroxy 2-(3-chlorophenyl)ethanamine (SR58611A), were examined on reinforcement of memory in day-old chicks. BRL37344 and CGP12177 facilitated memory, whereas SR58611A had no effect. The dose-response relationships of the β3-adrenoceptor agonists were challenged with the selective β3-adrenoceptor antagonist 3-(2-ethylphenoxy)-1-[(1S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) or the β2-adrenoceptor antagonist (-)propranolol. BRL 37344 appeared to act predominantly at β3-adrenoceptors at low doses and at β2-adrenoceptors at higher doses. Facilitation of labile into long-term storage by β3-adrenoceptor agonists appears to be a class action of these drugs.

KW - β-Adrenoceptor

KW - (Chick)

KW - Adrenoceptor

KW - Consolidation

KW - Memory

KW - Memory, labile

KW - Passive avoidance learning

UR - http://www.scopus.com/inward/record.url?scp=0035895562&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(01)00757-9

DO - 10.1016/S0014-2999(01)00757-9

M3 - Article

VL - 413

SP - 235

EP - 240

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -